Current Methods for Fluorescence-Based Universal Sequence-Dependent Detection of Nucleic Acids in Homogenous Assays and Clinical Applications

Abstract

BACKGROUND Specific and sensitive nucleic acid (NA) testing in research and clinical diagnostics is usually performed by use of labeled oligonucleotide probes. However, the use of target-specific fluorogenic probes increases the cost of analysis. Therefore, universal sequence-dependent (USD) NA detection methods have been developed to facilitate cost-effective target detection using standardized reagents. CONTENT We provide a comprehensive review of the current methods for fluorescence-based USD NA detection. Initially, we focus on the emergence of these methods as a means to overcome the shortcomings of common NA detection methods, such as hydrolysis probes and molecular beacons. Thereafter, we provide a critical evaluation of the individual detection methods. These methods include (a) target amplification with bipartite primers introducing a universal detection tag to the amplicon (UniPrimer PCR, universal fluorescence energy transfer probe PCR, attached universal duplex probe PCR, and universal strand displacement amplification) or combined with bipartite probes comprising a universal detection region (mediator probe PCR, universal strand displacement amplification, universal quenching probe PCR) and (b) amplification-independent assays employing either a universal variant of the invader assay or universal NA hybridization sensors. We discuss differences between the methods and review clinical applications. SUMMARY The current methods for USD NA testing are cost-effective and flexible and have concordant analytical performance in comparison with common probe-based techniques. They can detect any target sequence by the simple use of a label-free, low-cost primer or probe combined with a universal fluorogenic reporter. The methods differ in the number of target specificities, capability of multiplexing, and incubation requirements (isothermal/thermocycling). Extensive clinical applications comprise detection of single-nucleotide polymorphisms, study of gene expression, in situ PCR, and quantification of pathogen load.

A multianalyte PCR blood test outperforms single analyte ELISAs (chromogranin A, pancreastatin, neurokinin A) for neuroendocrine tumor detection

“…These are procedures that utilize multiple results derived from assays of various types, including molecular pathology assays, fluorescent in situ hybridization assays and non-nucleic acid based assays (e.g. proteins, polypeptides, lipids, carbohydrates) (Faltin et al 2013). …”

Fluorescent Nucleic Acid Analogues in Research and Clinical Diagnostics

“…The limit of target detection (LOD) is a crucial parameter and depends on several factors including the brightness of the applied dye, the analyte (i.e., DNA or RNA), the enzymatic requirements if any, and the type of the used optical system (Astakhova 2014;Demchenko 2009). PCR allows detection of individual molecules with any labeling method (Ganzel et al 2013;Faltin et al 2013;Weber and K€ oster 2013;Marshall et al 2013;Kuroda et al 2013). The same sensitivity can be now achieved using single-molecule spectroscopy Kusumi et al 2014;Shivanandan et al 2014).…”

A PCR blood test outperforms chromogranin A in carcinoid detection and is unaffected by proton pump inhibitors

“…breast cancer arrays (Mammaprint), fluorescent in situ hybridization assays, and non-nucleic acid-based assays (27). Algorithmic analyses, using the results of these assays as well as patient information (if available), are typically reported as a numeric score(s) or as a probability, often a risk probability (28), that can provide prognostic and predictive information, thereby aiding clinical decision-making (29).…”